GTP cyclohydrolase (GTP-CH) catalyzes the initial and regulatory step of tetrahydrobiopterin (BH-4) synthesis. BH-4 is the essential cofactor for the hydroxylation of phenylalanine (Phe), tyrosine (Tyr), and tryptophan (Trp). It may regulate Phe hydroxylase activity by acting as a negative effector of its activation. In neurons, BH-4 may be responsible for the phosphorylation of Tyr and Trp hydroxylases, which enhances their activities. Induction of GTP-CH followed by elevation of BH-4 level and enhancement of Tyr hydroxylase activity have been reported. Just as Tyr hydroxylase is a marker for dopamine, GTP-CH is a marker for BH-4. BH-4 deficiency may reflect a defect of this enzyme and/or one of its biosynthetic enzymes. Variant forms of hyperphenylalaninemia have been found to be caused by a deficiency of BH-4. Reduced levels of BH-4 in cerebrospinal fluids from patients with Parkinson's disease, torsion dystonias, senile dementia of Alzheimer type, Steel-Richardson syndrome, and Huntington's chorea have also been reported. Monotherapy with BH-4 has proven successful in some patients with these disorders. Mammalian GTP-CH may be an aggregate of enzymes, but the enzyme complex itself has not yet been systematically studied. The research plan proposes the following studies: 1. Purify GTP-CH to homogeneity from liver and brain of rat and human. 2. Study the enzyme properties and protein structure of the multiple forms of GTP-CH. 3. Investigate the in vitro and in vivo regulation of GTP-CH activity by endogenous and exogenous compounds. This study should generate important basic information on the chemistry and function of mammalian GTP-CH, and the co-regulation of GTP-CH activity and BH-4 levels in rat brain. This information should also shed light on the role of GTP-CH and/or BH-4 in the development and treatment of monoamine-related neurological and psychiatric disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS022997-02
Application #
3405910
Study Section
Biochemistry Study Section (BIO)
Project Start
1986-09-01
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Shen, R S; Zhang, Y X (1991) Antioxidation activity of tetrahydrobiopterin in pheochromocytoma PC 12 cells. Chem Biol Interact 78:307-19
Shen, R S (1991) Inhibition of dopamine autoxidation by tetrahydrobiopterin and NADH in the presence of dihydropteridine reductase. Neurotoxicology 12:201-8
Shen, R S; Alam, A; Zhang, Y X (1989) Human liver GTP cyclohydrolase I: purification and some properties. Biochimie 71:343-9
Shen, R S; Zhang, Y X; Perez-Polo, J R (1989) Regulation of GTP cyclohydrolase I and dihydropteridine reductase in rat pheochromocytoma PC 12 cells. J Enzyme Inhib 3:119-26
Shen, R S; Alam, A; Zhang, Y X (1988) Inhibition of GTP cyclohydrolase I by pterins. Biochim Biophys Acta 965:9-15
Kwan, S W; Shen, R S; Abell, C W (1987) An enzyme immunoassay for the quantitation of dihydropteridine reductase. Anal Biochem 164:391-6